To validate the involvement of STAT3 in the stemness, migration and invasion phenotypes of CD44s-promoted GC cells, a STAT3 activator (Colivelin) was administered to CD44s-knockdown GC cells. This evidence concerns the gene STAT3 and gastric cancer.